Literature DB >> 19708803

Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model.

Michael E Yurcheshen1, Thomas Guttuso, Michael McDermott, Robert G Holloway, Michael Perlis.   

Abstract

OBJECTIVE: The aim of this research was to analyze gabapentin's effect on Pittsburgh Sleep Quality Index (PSQI) scores in menopausal women.
METHODS: Secondary analysis of data from a cohort of menopausal women participating in a randomized, double-blind, placebo-controlled trial of gabapentin 300 mg three times daily (TID) for hot flashes. The outcomes of interest were PSQI global and factor scores at weeks 4 and 12.
RESULTS: Subjects randomized to gabapentin demonstrated improvement in the sleep quality factor score, compared to placebo-treated subjects, at 4 and 12 weeks (p < 0.03). There was also gabapentin-associated improvement in the global PSQI score (p = 0.004) and the sleep efficiency factor score (p = 0.05) at 4 weeks. There was no significant effect of gabapentin on the daily disturbance factor score.
CONCLUSIONS: Gabapentin may improve sleep quality in menopausal women with hot flashes. These results warrant further prospective investigation, with an emphasis on measuring subjective sleep quality and maintenance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19708803     DOI: 10.1089/jwh.2008.1257

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  17 in total

Review 1.  What is the role of sedating antidepressants, antipsychotics, and anticonvulsants in the management of insomnia?

Authors:  Catherine McCall; W Vaughn McCall
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

2.  A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.

Authors:  Russell P Rosenberg; Steven G Hull; D Alan Lankford; David W Mayleben; David J Seiden; Sandy A Furey; Shyamalie Jayawardena; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

3.  A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.

Authors:  Sandy A Furey; Steven G Hull; Mark T Leibowitz; Shyamalie Jayawardena; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

Review 4.  Sleep and Sleep Disorders in the Menopausal Transition.

Authors:  Fiona C Baker; Laura Lampio; Tarja Saaresranta; Päivi Polo-Kantola
Journal:  Sleep Med Clin       Date:  2018-09

5.  Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: a randomized trial.

Authors:  Sheila N Garland; Sharon X Xie; Qing Li; Christina Seluzicki; Coby Basal; Jun J Mao
Journal:  Menopause       Date:  2017-05       Impact factor: 2.953

6.  Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Shrujal Baxi; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Elizabeth Kvale; Robin M Lally; Terry S Langbaum; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Deborah A Freedman-Cass; Nicole R McMillian
Journal:  J Natl Compr Canc Netw       Date:  2017-09       Impact factor: 11.908

7.  Nighttime awakenings responding to gabapentin therapy in late premenopausal women: a case series.

Authors:  Thomas Guttuso
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

8.  A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes.

Authors:  Wendy Y Chen; Anita Giobbie-Hurder; Kathryn Gantman; Jennifer Savoie; Rochelle Scheib; Leroy M Parker; Eva S Schernhammer
Journal:  Breast Cancer Res Treat       Date:  2014-04-10       Impact factor: 4.872

9.  Increases in duration of first uninterrupted sleep period are associated with improvements in PSQI-measured sleep quality.

Authors:  Donald L Bliwise; Tove Holm-Larsen; Sandra Goble
Journal:  Sleep Med       Date:  2014-06-13       Impact factor: 3.492

10.  Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements?

Authors:  Shivani Shinde; Pamela Gordon; Prashant Sharma; James Gross; Mellar P Davis
Journal:  Support Care Cancer       Date:  2014-08-29       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.